Support the fact-based journalism you rely on with a donation to Marketplace today. Give Now!

What does Trump's win mean for Biden's regulatory targets?

Nov 14, 2024
Some companies with ongoing legal and regulatory disputes with federal agencies have an incentive to wait for the new, likely more business-friendly, administration to come into power.
Patrick T. Fallon/AFP via Getty Images

The push to revive limits on the abortion pill

Oct 25, 2024
In this week's newsletter, we’re looking at how states are reviving lawsuits to block mail-order abortion pills, the FTC's new rule that promised to curtail fake consumer reviews, and we do the numbers on down payment assistance programs.
Photo illustration by Anna Moneymaker/Getty Images

New FTC rule aims to simplify subscription cancellations

Sep 3, 2024
Firms that sell subscriptions can count on significant revenue boosts from consumer spaciness. It helps if customers have to jump through hoops once they realize they’re shelling out for a product they don’t need. 
The FTC rule should be finalized soon, but many firms have already gotten in the habit of offering clear disclosures and easy cancellation. 
aurence Dutton/Getty Images

Grocery prices are high. But is that suspicious?

Aug 5, 2024
The Federal Trade Commission just announced that the agency would investigate whether companies are inflating grocery prices.
"Grocery prices have been running much higher than average inflation," said Lindsay Owens of the Groundwork Collaborative.
Spencer Platt/Getty Images

FTC investigates companies' use of surveillance pricing

Jul 25, 2024
The Federal Trade Commission wants to know how firms are using surveillance pricing as ever more data on consumers is collected.
Mandel Ngan/AFP via Getty Images

Why the FTC is looking at pharmacy benefit managers and their role in drug pricing

Jul 11, 2024
The Federal Trade Commission says companies like CVS Caremark, Express Scripts and OptumRx are artificially driving up prices for medications.
The Federal Trade Commission says companies like CVS Caremark, Express Scripts and OptumRx are artificially driving up prices for medications.
SDI Productions/Getty Images

The biggest middleman in the prescription drug supply chain now makes drugs

May 14, 2024
With pharmaceutical mergers more common, the FTC is taking a hard look at pharmacy benefit managers and antitrust concerns.
In 2023, CVS founded Cordavis, a wholly owned subsidiary of CVS Health, to manufacture biosimilar prescription drugs.
Brendan Smialowski/AFP via Getty Images

For public good, not for profit.

Private equity's role in health care is under increasing scrutiny

Apr 8, 2024
A Senate committee and two federal agencies are taking closer looks at how private equity’s ownership of hospitals and physician staffing companies is affecting health care.
"About 25% of emergency room departments are staffed by private equity-owned physician companies," said Sabrina Howell of NYU’s Stern School of Business.
Spencer Platt/Getty Images

New FTC rule aims to crack down on impersonation scams

Apr 2, 2024
Posing as a bank or other trusted institution to cheat the public will be outlawed and the agency will get new tools to go after scammers.
Scammers often may already have lots of your personal information thanks to data breaches, allowing them to sound more convincing.
Ton Photograph/Getty Images

FTC proposes new rule to increase transparency around junk fees

Oct 11, 2023
One area particularly hard hit by these extra charges: apartment rent. And the fees aren't always disclosed before tenants sign the lease.
The proposed FTC rule would require landlords and management companies to tell prospective tenants about extra fees, like for filing online maintenance requests or calculating each apartment’s share of the utilities, before they sign a lease.
Joe Raedle/Getty Images